Enzyme inhibition assay for pyruvate dehydrogenase complex: Clinical utility for the diagnosis of primary biliary cirrhosis

World Journal of Gastroenterology

Volumn 11, Issue 43, 2005, Pages 6735-6739

  Omagari, Katsuhisa ^a   Hazama, Hiroaki ^a   Kohno, Shigeru ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

2 oxo acid; Antimitochondrial antibody; Dehydrogenase complex; Enzyme inhibition assay; Primary biliary cirrhosis

Indexed keywords

2 OXOACID DEHYDROGENASE; MITOCHONDRION ANTIBODY; OXOGLUTARATE DEHYDROGENASE; PYRUVATE DEHYDROGENASE COMPLEX;

BLOOD SAMPLING; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOBLOTTING; IMMUNOFLUORESCENCE TEST; LABORATORY DIAGNOSIS; MASS SCREENING; PRIMARY BILIARY CIRRHOSIS; REVIEW; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

EID: 30744458337     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i43.6735     Document Type: Review

References (20)

1. Kaplan MM. Primary biliary cirrhosis. N Engl J Med 1996; 335: 1570-1580
2. Talwalkar JA, Lindor KD. Primary biliary cirrhosis. Lancet 2003; 362: 53-61
3. Gershwin ME, Mackay I, Coppel R, Nakanuma Y. Clinical, immunologic and molecular features of primary biliary cirrhosis. Semin Clin Immunol 1994; 7: 5-16
4. Kadokawa Y, Omagari K, Ohba K, Masuda J, Hazama H, Kinoshita H, Ohnita K, Mizuta Y, Tanioka H, Imanishi T, Kohno S. Does the diagnosis of primary biliary cirrhosis or autoimmune cholangitis depend on the "phase" of the disease? Liver Int 2005: 25: 317-324
5. Moteki S, Leung PSC, Coppel RL, Dickson ER, Kaplan MM, MunozS, Gershwin ME. Use of a designer triple expression hybrid clone for three different lipoyl domains for the detection of antimitochondrial autoantibodies. Hepatology 1996; 24: 97-103
6. Jensen WA, Jois JA, Murphy P, De Giorgio J, Brown B, Rowley MJ, Mackay IR. Automated enzymatic mitochondrial antibody assay for the diagnosis of primary biliary cirrhosis. Clin Chem Lab Med 2000; 38: 753-758
7. Miyakawa H, Tanaka A, Kikuchi K, Matsushita M, Kitazawa E, Kawaguchi N, Fujikawa H, Gershwin ME. Detection of antimitochondrial autoantibodies in immunofluorescent AMA-negative patients with primary biliary cirrhosis using recombinant autoantigerts. Hepatology 2001; 34: 243-248
8. Kadokawa Y, Omagari K, Hazama H, Ohba K, Masuda J, Kinoshita H, Hayashida K, Isomoto H, Mizuta Y, Murase K, Murata I, Kohno S. Evaluation of newly developed ELISA using "MESACUP-2 Test Mitochondrial M2" kit for the diagnosis of primary biliary cirrhosis. Clin Biochem 2003; 36: 203-210
9. Takemura M, Ohya K, Kojima K. Fundamental evaluation of "MESACUP-2 Test Mitochondrial M2". Jpn J Med Pharm Sci 2001; 46: 809-816 (in Japanese)
10. Kitami N, Komada T, Ishii H, Shimizu H, Adachi H, Yamaguchi Y, Kitamura T, Oide H, Miyazaki A, Ishikawa M, Endo K, Watanabe S, Yokoi Y, Sato N. Immunological study of anti-M2 in antimitochondrial antibody-negative primary biliary cirrhosis. Intern Med 1995; 34: 496-501
11. Kinoshita H, Omagari K, Matsuo I, Yamaguchi K, Ikuno N, Kohno S. Frequency of IgG, IgM, and IgA class autoantibodies against 2-oxo-acid dehydrogenase complex in 102 Japanese patients with primary biliary cirrhosis. Hepatol Res 1999; 15: 163-171
12. Masuda J, Omagari K, Miyakawa H, Hazama H, Ohba K, Kinoshita H, Matsuo I, Isomoto H, Murata I, Kohno S. Clinical significance of positive immunoblotting but negative immunofluorescence for antimitochondrial antibodies in patients with liver diseases other than primary biliary cirrhosis. Autoimmunity 2002; 35: 135-141
13. Teoh K-L, Rowley MJ, Zafirakis H, Dickson ER, Wiesner RH, Gershwin ME, Mackay IR. Enzyme inhibitory autoantibodies to pyruvate dehydrogenase complex in primary biliary cirrhosis: Applications of a semiautomated assay. Hepatology 1994; 20: 1220-1224
14. Schmit P, Gilson G, Humbel RL. Evaluation of an automated enzyme inhibition assay for the detection of anti-mitochondrial M2 autoantibodies. Clin Chem 1999; 45: 2287-2289
15. Jois J, Omagari K, Rowley MJ, Anderson J, Mackay IR. Enzyme inhibitory antibody to pyruvate dehydrogenase: diagnostic utility in primary biliary cirrhosis. Ann Clin Biochem 2000; 37: 67-73
16. Hazama H, Omagari K, Masuda J, Ohba K, Kinoshita H, Matsuo I, Isomoto H, Mizuta Y, Murase K, Murata I, Kohno S. Automated enzymatic mitochondrial antibody assay for the diagnosis of primary biliary cirrhosis: applications of a routine diagnostic tool for the detection of antimitochondrial antibodies. J Gastroenterol Hepatol 2002; 17: 316-323
17. Bassendine MF, Jones DEJ, Antimitochondrial and other autoantibodies in primary biliary cirrhosis. In: Krawitt EL, Wiesner RH, Nishioka M. Autoimmune Liver Diseases. Amsterdam: Elsevier Science BV, 1998; 287-304
18. Teoh K-L, Rowley MJ, Mackay IR. An automated microassay for enzyme inhibitory effects of M2 antibodies in primary biliary cirrhosis. Liver 1991; 11: 287-291
19. Hazama H, Omagari K, Masuda J, Kinoshita H, Ohba K, Sakimura K, Matsuo I, Isomoto H, Murase K, Murata I, Kohno S. Serial changes in enzyme inhibitory antibody to pyruvate dehydrogenase complex during the course of primary biliary cirrhosis. J Clin Lab Anal. 2000; 14: 208-213
20. Omagari K, Rowley MJ, Jois JA, Feeney SJ, Komatsu K, Maeda T, Onishi S, Yamazaki K, Suzuki K, Galperin C, Mackay IR. Immunoreactivity of antimitochondrial autoantibodies in patients with primary biliary cirrhosis. J Gastroenterol 1996; 31: 61-68